Biologic and Epidemiologic Markers of Endometriosis (BEME)

Summary

The purpose of this study is to identify biomarkers of benign gynecologic conditions, with a particular focus on endometriosis. In endometriosis, uterus-like tissue grows in other parts of the body. Biomarkers are molecules found in blood, body fluids, and tissues that can be a sign of a normal or abnormal process of a disease. Endometriosis is difficult to diagnose because symptoms are non-specific and varied; some women may not even show symptoms. The study aims to understand patient lifestyle factors, outcomes and experiences of pain and infertility associated with the disease. In so doing, researchers hope to develop novel ways to diagnose endometriosis without the need for surgery. Participants will be asked to complete questionnaires about their reproductive health and history. Researchers will also collect biological specimens (such as tissue and blood), and medical records will be reviewed.


Inclusion Criteria

Not Available


Study Location(s)

  • Beverly
  • Cedars-Sinai Cancer at SOCC



Full Title

Biologic and Epidemiologic Markers of Endometriosis

Details
Disease Type/Condition

Other

Principal Investigator

Lawrenson, Kate

Co-Investigators

Marc Goodman

Age Group

Adult

Phase

N/A

IRB Number

STUDY00000063


Contact
Phone
310-423-6252
Email
clinicaltrials@cshs.org
Want to join the study or
learn more?

Details
Disease Type/Condition

Other

Principal Investigator

Lawrenson, Kate

Age Group

Adult

Phase

N/A

IRB Number

BB-STUDY00000063


Contact
Phone
310-423-6252
Email
clinicaltrials@cshs.org
Want to join the study or
learn more?